glp-1 gastric intestinal obstruction class action in michigan semaglutide gastrointestinal law office GLP-1s are a hot topic for diabetes treatment at Texas Ozempic Lawsuit Attorney Ozempic Lawsuit: July 2026 Blindness

A 2022 study by the UK Parliament found that, in England, 28% of adults were obese and a further 36% were overweight

These lawsuits focus on claims that Ozempic has caused serious gastrointestinal issues, including gastroparesis and pancreatitis, among other complications

Why Ozempic Isn't a Weight Loss Solution at Klinic Although Ozempic and Wegovy share the active ingredient semaglutide, they serve distinct purposes

Clinical trials supporting semaglutide for weight loss enrolled patients who took their injection on the same day every week, so treatment outcomes reflect that adherence pattern

If you have type 2 diabetes or non-diabetic hyperglycaemia (prediabetes) and are on combination therapy, an inadvertently shortened dosing interval might increase the risk of hypoglycaemia